In addition, an increase of more than 25% of CADM1+ CD4+ cells may be one of the risk factors of ATL development in patients with HTLV-1 carriers, including HAM/TSP patients [10,24]. The gene discussed is CD4; the disease is tropical spastic paraparesis.